Stockreport

SAB Biotherapeutics to Present at the American Diabetes Association 84th Scientific Sessions [Yahoo! Finance]

SAB Biotherapeutics, Inc.  (SABS) 
PDF with a novel immunotherapy platform developing a human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D), today announc [Read more]